Selected research
Industry Growth & Trends
Global NAD+ Booster Capsule Industry Growth and Trends Forecast to 2032
Market perspective
The global NAD+ Booster Capsule market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for NAD+ Booster Capsule is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of NAD+ Booster Capsule include EffePharm, Kingdomway, GeneHarbor, Bontac, NOMON Co., Ltd. (Teijin), Mirailab Bioscience Inc. (Shinkowa Pharmaceutical), Maac10 Formulas, Herbalmax and Genex Formulas, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global NAD+ Booster Capsule market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The NAD+ Booster Capsule market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NAD+ Booster Capsule market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NAD+ Booster Capsule.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global NAD+ Booster Capsule market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
NAD+ Booster Capsule Market by Company
EffePharm
Kingdomway
GeneHarbor
Bontac
NOMON Co., Ltd. (Teijin)
Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
Maac10 Formulas
Herbalmax
Genex Formulas
EZZ
Elysium Health
Chromadex
CELFULL
NAD+ Booster Capsule Segment by Type
Content <98%
Content ≥98%
NAD+ Booster Capsule Segment by Application
Health Care Products
Beauty Products
Others
NAD+ Booster Capsule Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NAD+ Booster Capsule market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NAD+ Booster Capsule and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NAD+ Booster Capsule.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NAD+ Booster Capsule manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of NAD+ Booster Capsule in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Content <98%
- Content ≥98%
Applications
- Health Care Products
- Beauty Products
- Others
Companies covered
- EffePharm
- Kingdomway
- GeneHarbor
- Bontac
- NOMON Co., Ltd. (Teijin)
- Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
- Maac10 Formulas
- Herbalmax
- Genex Formulas
- EZZ
- Elysium Health
- Chromadex
- CELFULL
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global NAD+ Booster Capsule Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global NAD+ Booster Capsule Sales Estimates and Forecasts (2021-2032)
- 1.3 NAD+ Booster Capsule Market by Type
- 1.3.1 Content <98%
- 1.3.2 Content ≥98%
- 1.4 Global NAD+ Booster Capsule Market Size by Type
- 1.4.1 Global NAD+ Booster Capsule Market Size Overview by Type (2021-2032)
- 1.4.2 Global NAD+ Booster Capsule Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global NAD+ Booster Capsule Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America NAD+ Booster Capsule Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe NAD+ Booster Capsule Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific NAD+ Booster Capsule Sales Breakdown by Type (2021-2026)
- 1.5.4 South America NAD+ Booster Capsule Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa NAD+ Booster Capsule Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 NAD+ Booster Capsule Industry Trends
- 2.2 NAD+ Booster Capsule Industry Drivers
- 2.3 NAD+ Booster Capsule Industry Opportunities and Challenges
- 2.4 NAD+ Booster Capsule Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by NAD+ Booster Capsule Revenue (2021-2026)
- 3.2 Global Top Players by NAD+ Booster Capsule Sales (2021-2026)
- 3.3 Global Top Players by NAD+ Booster Capsule Price (2021-2026)
- 3.4 Global NAD+ Booster Capsule Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global NAD+ Booster Capsule Major Company Production Sites & Headquarters
- 3.6 Global NAD+ Booster Capsule Company, Product Type & Application
- 3.7 Global NAD+ Booster Capsule Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global NAD+ Booster Capsule Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 NAD+ Booster Capsule Players Market Share by Revenue in 2025
- 3.8.3 2025 NAD+ Booster Capsule Tier 1, Tier 2, and Tier 3
4 NAD+ Booster Capsule Regional Status and Outlook
- 4.1 Global NAD+ Booster Capsule Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global NAD+ Booster Capsule Historic Market Size by Region
- 4.2.1 Global NAD+ Booster Capsule Sales in Volume by Region (2021-2026)
- 4.2.2 Global NAD+ Booster Capsule Sales in Value by Region (2021-2026)
- 4.2.3 Global NAD+ Booster Capsule Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global NAD+ Booster Capsule Forecasted Market Size by Region
- 4.3.1 Global NAD+ Booster Capsule Sales in Volume by Region (2027-2032)
- 4.3.2 Global NAD+ Booster Capsule Sales in Value by Region (2027-2032)
- 4.3.3 Global NAD+ Booster Capsule Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 NAD+ Booster Capsule by Application
- 5.1 NAD+ Booster Capsule Market by Application
- 5.1.1 Health Care Products
- 5.1.2 Beauty Products
- 5.1.3 Others
- 5.2 Global NAD+ Booster Capsule Market Size by Application
- 5.2.1 Global NAD+ Booster Capsule Market Size Overview by Application (2021-2032)
- 5.2.2 Global NAD+ Booster Capsule Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global NAD+ Booster Capsule Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America NAD+ Booster Capsule Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe NAD+ Booster Capsule Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific NAD+ Booster Capsule Sales Breakdown by Application (2021-2026)
- 5.3.4 South America NAD+ Booster Capsule Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa NAD+ Booster Capsule Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 EffePharm
- 6.1.1 EffePharm Company Information
- 6.1.2 EffePharm Business Overview
- 6.1.3 EffePharm NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 EffePharm NAD+ Booster Capsule Product Portfolio
- 6.1.5 EffePharm Recent Developments
- 6.2 Kingdomway
- 6.2.1 Kingdomway Company Information
- 6.2.2 Kingdomway Business Overview
- 6.2.3 Kingdomway NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Kingdomway NAD+ Booster Capsule Product Portfolio
- 6.2.5 Kingdomway Recent Developments
- 6.3 GeneHarbor
- 6.3.1 GeneHarbor Company Information
- 6.3.2 GeneHarbor Business Overview
- 6.3.3 GeneHarbor NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 GeneHarbor NAD+ Booster Capsule Product Portfolio
- 6.3.5 GeneHarbor Recent Developments
- 6.4 Bontac
- 6.4.1 Bontac Company Information
- 6.4.2 Bontac Business Overview
- 6.4.3 Bontac NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Bontac NAD+ Booster Capsule Product Portfolio
- 6.4.5 Bontac Recent Developments
- 6.5 NOMON Co., Ltd. (Teijin)
- 6.5.1 NOMON Co., Ltd. (Teijin) Company Information
- 6.5.2 NOMON Co., Ltd. (Teijin) Business Overview
- 6.5.3 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 NOMON Co., Ltd. (Teijin) NAD+ Booster Capsule Product Portfolio
- 6.5.5 NOMON Co., Ltd. (Teijin) Recent Developments
- 6.6 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical)
- 6.6.1 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Company Information
- 6.6.2 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Business Overview
- 6.6.3 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) NAD+ Booster Capsule Product Portfolio
- 6.6.5 Mirailab Bioscience Inc. (Shinkowa Pharmaceutical) Recent Developments
- 6.7 Maac10 Formulas
- 6.7.1 Maac10 Formulas Company Information
- 6.7.2 Maac10 Formulas Business Overview
- 6.7.3 Maac10 Formulas NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Maac10 Formulas NAD+ Booster Capsule Product Portfolio
- 6.7.5 Maac10 Formulas Recent Developments
- 6.8 Herbalmax
- 6.8.1 Herbalmax Company Information
- 6.8.2 Herbalmax Business Overview
- 6.8.3 Herbalmax NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Herbalmax NAD+ Booster Capsule Product Portfolio
- 6.8.5 Herbalmax Recent Developments
- 6.9 Genex Formulas
- 6.9.1 Genex Formulas Company Information
- 6.9.2 Genex Formulas Business Overview
- 6.9.3 Genex Formulas NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Genex Formulas NAD+ Booster Capsule Product Portfolio
- 6.9.5 Genex Formulas Recent Developments
- 6.10 EZZ
- 6.10.1 EZZ Company Information
- 6.10.2 EZZ Business Overview
- 6.10.3 EZZ NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 EZZ NAD+ Booster Capsule Product Portfolio
- 6.10.5 EZZ Recent Developments
- 6.11 Elysium Health
- 6.11.1 Elysium Health Company Information
- 6.11.2 Elysium Health Business Overview
- 6.11.3 Elysium Health NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Elysium Health NAD+ Booster Capsule Product Portfolio
- 6.11.5 Elysium Health Recent Developments
- 6.12 Chromadex
- 6.12.1 Chromadex Company Information
- 6.12.2 Chromadex Business Overview
- 6.12.3 Chromadex NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Chromadex NAD+ Booster Capsule Product Portfolio
- 6.12.5 Chromadex Recent Developments
- 6.13 CELFULL
- 6.13.1 CELFULL Company Information
- 6.13.2 CELFULL Business Overview
- 6.13.3 CELFULL NAD+ Booster Capsule Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 CELFULL NAD+ Booster Capsule Product Portfolio
- 6.13.5 CELFULL Recent Developments
7 North America by Country
- 7.1 North America NAD+ Booster Capsule Sales by Country
- 7.1.1 North America NAD+ Booster Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America NAD+ Booster Capsule Sales by Country (2021-2026)
- 7.1.3 North America NAD+ Booster Capsule Sales Forecast by Country (2027-2032)
- 7.2 North America NAD+ Booster Capsule Market Size by Country
- 7.2.1 North America NAD+ Booster Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America NAD+ Booster Capsule Market Size by Country (2021-2026)
- 7.2.3 North America NAD+ Booster Capsule Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe NAD+ Booster Capsule Sales by Country
- 8.1.1 Europe NAD+ Booster Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe NAD+ Booster Capsule Sales by Country (2021-2026)
- 8.1.3 Europe NAD+ Booster Capsule Sales Forecast by Country (2027-2032)
- 8.2 Europe NAD+ Booster Capsule Market Size by Country
- 8.2.1 Europe NAD+ Booster Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe NAD+ Booster Capsule Market Size by Country (2021-2026)
- 8.2.3 Europe NAD+ Booster Capsule Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific NAD+ Booster Capsule Sales by Country
- 9.1.1 Asia-Pacific NAD+ Booster Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific NAD+ Booster Capsule Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific NAD+ Booster Capsule Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific NAD+ Booster Capsule Market Size by Country
- 9.2.1 Asia-Pacific NAD+ Booster Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific NAD+ Booster Capsule Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific NAD+ Booster Capsule Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America NAD+ Booster Capsule Sales by Country
- 10.1.1 South America NAD+ Booster Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America NAD+ Booster Capsule Sales by Country (2021-2026)
- 10.1.3 South America NAD+ Booster Capsule Sales Forecast by Country (2027-2032)
- 10.2 South America NAD+ Booster Capsule Market Size by Country
- 10.2.1 South America NAD+ Booster Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America NAD+ Booster Capsule Market Size by Country (2021-2026)
- 10.2.3 South America NAD+ Booster Capsule Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa NAD+ Booster Capsule Sales by Country
- 11.1.1 Middle East and Africa NAD+ Booster Capsule Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa NAD+ Booster Capsule Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa NAD+ Booster Capsule Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa NAD+ Booster Capsule Market Size by Country
- 11.2.1 Middle East and Africa NAD+ Booster Capsule Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa NAD+ Booster Capsule Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa NAD+ Booster Capsule Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 NAD+ Booster Capsule Value Chain Analysis
- 12.1.1 NAD+ Booster Capsule Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 NAD+ Booster Capsule Production Mode & Process
- 12.2 NAD+ Booster Capsule Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 NAD+ Booster Capsule Distributors
- 12.2.3 NAD+ Booster Capsule Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst